| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 1 |
| 1 | DILUENT | 1 |
| 2 | DUPILUMAB | 1 |
| 3 | TUBERCULIN PURIFIED PROTEIN DERIVATIVE | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | DILUENT | 1 | 0.0010 |
| 1 | TUBERCULIN PURIFIED PROTEIN DERIVATIVE | 1 | 0.0005 |
| 2 | DUPILUMAB | 1 | 0.0000 |
| 3 | ADALIMUMAB | 1 | 0.0000 |
| # | Drug class | Count |
|---|---|---|
| 0 | Insulin Analog [EPC] | 1 |
| 1 | Interleukin-4 Receptor alpha Antagonist [EPC] | 1 |
| 2 | Skin Test Antigen [EPC] | 1 |
| 3 | Tuberculosis Skin Test [EPC] | 1 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Skin Test Antigen [EPC] | 1 | 0.0005 |
| 1 | Insulin Analog [EPC] | 1 | 0.0000 |
| 2 | Interleukin-4 Receptor alpha Antagonist [EPC] | 1 | 0.0000 |